Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Inovio Pharmaceuticals)"
Count: 54
Selected: 0
| NCT ID | Title |
|---|
| NCT05430958 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers | ||
| NCT04642638 | Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure | ||
| NCT04588428 | Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers | ||
| NCT04398433 | INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) | ||
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | ||
| NCT04093076 | Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana | ||
| NCT03805984 | Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers | ||
| NCT03721978 | REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | ||
| NCT03502785 | INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma | ||
| NCT03499795 | VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 | ||
| NCT03491683 | INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) | ||
| NCT03185013 | REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | ||
| NCT03180684 | Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) | ||
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | ||
| NCT02514213 | Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer | ||
| NCT02464670 | Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers | ||
| NCT02431312 | Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects | ||
| NCT02241369 | Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies | ||
| NCT02172911 | A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer | ||
| NCT02163057 | Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma | ||
| NCT01405885 | A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus | ||
| NCT01403155 | A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001 | ||
| NCT01304524 | A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3 | ||
| NCT01188850 | Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100 | ||
| NCT01142362 | Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults | ||
| NCT01082692 | Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants | ||
| NCT00685412 | Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 | ||
| NCT00198328 | Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma | ||
| NCT00198315 | Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma | ||
| NCT00198276 | Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer | ||
| NCT00198263 | Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer | ||
| NCT04367675 | INO 5401 Vaccination in BRCA1/2 Mutation Carriers | ||
| NCT03831503 | A Study of INO-A002 in Healthy Dengue Virus-naive Adults | ||
| NCT03674125 | Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection | ||
| NCT02887482 | GLS-5700 in Dengue Virus Seropositive Adults | ||
| NCT02809443 | GLS-5700 in Healthy Volunteers | ||
| NCT02772003 | DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | ||
| NCT02027116 | Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection | ||
| NCT01587131 | DNA-based Influenza Vaccine in the Elderly | ||
| NCT01335711 | CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects | ||
| NCT01184976 | Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males | ||
| NCT00563173 | Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients | ||
| NCT03721718 | Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers | ||
| NCT02670187 | Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers | ||
| NCT02501278 | A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer | ||
| NCT04447781 | Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 | ||
| NCT00721461 | A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001) | ||
| NCT05293249 | dMAbs for Prevention of COVID-19 | ||
| NCT04906629 | INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees | ||
| NCT03606213 | Therapeutic Vaccination in Treated HIV Disease |
